LUCY
Innovative Eyewear Inc.
NASDAQ: LUCY · HEALTHCARE · MEDICAL INSTRUMENTS & SUPPLIES
$1.05
+0.96% today
Updated 2026-04-30
Market cap
$6.49M
P/E ratio
—
P/S ratio
2.44x
EPS (TTM)
$-1.90
Dividend yield
—
52W range
$1 – $5
Volume
0.1M
Innovative Eyewear Inc. (LUCY) Financial statements
SEC filings — annual and quarterly data.
Profit margin
-285.20%
Operating margin
-260.40%
ROE
-83.60%
ROA
-53.10%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2019 | $4821.00 | $-109427.00 | -60.44% | -2,269.80% | -2,269.80% |
| 2020 | $56997.00 | $-768184.00 | -30.30% | -1,145.69% | -1,347.76% |
| 2021 | $690670.00 | $-3.24M | 21.47% | -464.05% | -469.76% |
| 2022 | $659788.00 | $-5.68M | -8.53% | -845.22% | -861.16% |
| 2023 | $1.15M | $-6.66M | -10.35% | -594.85% | -578.18% |
| 2024 | $1.64M | $-7.77M | 13.15% | -484.20% | -474.60% |
| 2025 | $2.66M | $-7.59M | 21.32% | -319.16% | -285.20% |